GRA Eminent Scholar leads HIV/AIDS research consortium

July 18, 2011 at 3:05 pm Leave a comment

The National Institutes of Health has awarded a consortium of leading vaccine researchers at Emory University and partner institutions
a $26 million grant aimed at developing an effective HIV/AIDS vaccine.  The Emory-led consortium received the highest score among applicants for this competitive award, the largest ever for the Emory School of Medicine Department of Pathology.

The five-year program, led by GRA Eminent Scholar Eric Hunter, Ph.D., will focus on simian immunodeficiency virus (SIV) in nonhuman primates to better understand disease transmission and immune response.  SIV is similar to HIV in humans. GRA Eminent Scholars Max Cooper and Guido Silvestri are also part of the consortium.  Read more here> and here>

Entry filed under: GRA Eminent Scholars, News. Tags: .

Bringing precision to vision testing GRA VentureLab company awarded $3 million from NIH to advance ischemia research

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


Categories

Feeds


Follow

Get every new post delivered to your Inbox.